CTOs on the Move

Hospicelink

www.hospicelink.com

 
Hospicelink has created a nationally recognized , award winning software solution, specifically focused on the unique relationship between Hospice Companies and DME Providers. Although the needs of each Company can be vastly different, we understand the pressures in today`s marketplace and the difficulties these create for the industry. Hospicelink has addressed the challenges of providing optimal care while maintaining compliance and improving operational efficiencies, enabling your staff to balance multiple responsibilities.    Hospicelink has a proven track record of helping clients solve these problems through our comprehensive set of innovative solutions. Our state-of-the-art application assists Hospice Companies and DME Providers with the ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Jamey Taylor
Chief Technology Officer and Chief Information Security Officer Profile

Similar Companies

Refrigerative Supply

Refrigerative Supply is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ARTANN Laboratories (Main)

ARTANN Laboratories (Main) is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Med Exec International

Med Exec International is a Glendale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biomedical Polymers

Biomedical Polymers, Inc. is a quality manufacturer of plastic consumables for research and medical diagnostic laboratories. Our products are designed and manufactured to the highest quality standards. We offer a wide selection of products sold through

BioSig

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.